Nonselective beta blockers, hepatic decompensation, and mortality in cirrhosis: A national cohort study.
Marina SerperDavid E KaplanTamar H TaddeiElliot B TapperJordana B CohenNadim MahmudPublished in: Hepatology (Baltimore, Md.) (2022)
There is an ongoing need to noninvasively identify patients who may benefit from NSBBs for the prevention of hepatic decompensation.